1-3 of 3
Mengjie Ding
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world analysis of axicabtagene ciloleucel (axi-cel) as consolidation therapy following first-line treatment in B-cell lymphoma with high-risk factors

Free
Jieming Zhang, Mengjie Ding, Feifei Nan, Xiaorui Fu, Yu Chang, Lei Zhang, Mingzhi Zhang, Xudong Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 8015.
https://doi.org/10.1182/blood-2025-8015
Published: 2025
Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Free
Xudong Zhang, Mengke Fan, Wenhua Wang, Jingjing Wu, Shanshan Ma, Meng Dong, Linan Zhu, Xiaolong Wu, Xiaoyan Feng, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Yu Chang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Mengjie Ding, Jieming Zhang, Lei Zhang, Mingzhi Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6458.
https://doi.org/10.1182/blood-2024-202107
Published: 2024
Journal Articles

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Free
Jingjing Wu, Fenghua Gao, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Linan Zhu, Xudong Zhang, Xiaorui Fu, Zhenchang Sun, MD, PhD, Meng Dong, Mengjie Ding, Hui Yu, Feifei Nan, Jiaqin Yan, Yu Chang, Xiaolong Wu, Zhiyuan Zhou, Mingzhi Zhang, MD, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-137449
Published: 2020